Bell Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,175
| Closed | -$228K | – | 191 |
|
|
2024
Q3 | $228K | Hold |
1,175
| – | – | 0.03% | 164 |
|
|
2024
Q2 | $272K | Hold |
1,175
| – | – | 0.02% | 168 |
|
|
2024
Q1 | $253K | Hold |
1,175
| – | – | 0.02% | 173 |
|
|
2023
Q4 | $304K | Hold |
1,175
| – | – | 0.03% | 155 |
|
|
2023
Q3 | $302K | Hold |
1,175
| – | – | 0.03% | 154 |
|
|
2023
Q2 | $335K | Buy |
1,175
+1
| +0.1% | +$285 | 0.04% | 155 |
|
|
2023
Q1 | $326K | Buy |
1,174
+42
| +4% | +$11.7K | 0.03% | 155 |
|
|
2022
Q4 | $313K | Hold |
1,132
| – | – | 0.04% | 154 |
|
|
2022
Q3 | $302K | Sell |
1,132
-25
| -2% | -$6.67K | 0.04% | 148 |
|
|
2022
Q2 | $236K | Buy |
1,157
+32
| +3% | +$6.53K | 0.03% | 184 |
|
|
2022
Q1 | $237K | Hold |
1,125
| – | – | 0.03% | 163 |
|
|
2021
Q4 | $270K | Hold |
1,125
| – | – | 0.03% | 156 |
|
|
2021
Q3 | $318K | Hold |
1,125
| – | – | 0.04% | 142 |
|
|
2021
Q2 | $390K | Hold |
1,125
| – | – | 0.05% | 130 |
|
|
2021
Q1 | $315K | Hold |
1,125
| – | – | 0.05% | 142 |
|
|
2020
Q4 | $275K | Sell |
1,125
-200
| -15% | -$48.9K | 0.04% | 143 |
|
|
2020
Q3 | $376K | Hold |
1,325
| – | – | 0.07% | 114 |
|
|
2020
Q2 | $355K | Hold |
1,325
| – | – | 0.07% | 118 |
|
|
2020
Q1 | $419K | Sell |
1,325
-5
| -0.4% | -$1.58K | 0.09% | 104 |
|
|
2019
Q4 | $395K | Hold |
1,330
| – | – | 0.07% | 119 |
|
|
2019
Q3 | $310K | Buy |
1,330
+1
| +0.1% | +$233 | 0.06% | 135 |
|
|
2019
Q2 | $311K | Buy |
+1,329
| New | +$311K | 0.07% | 127 |
|